healthcare

Just 10% of investors anticipate V-shaped recovery

To help Schroders rebalance portfolio

Eye on large-cap pharma and biotech

Backs China vs US post-recovery

After a torrid three weeks, financial markets stabilised in recent days in response to the stimulus packages announced both by central banks and governments.

Up to 51% of dividends could be cut

AI, telemedicine and medical devices

Outlooks for the biotech sector

Three key drivers of change

Last year's contraction of manufacturing and industrial output was the third of the current economic cycle, influenced by dollar strength, the trade war, and the impact of strikes at General Motors and the grounding of the Boeing 737 Max.